OUR MOTIVATION
only
10%
of cancer patients benefit from approved therapies
95%
of anti-cancer drugs fail to be approved for patients due to lack of efficacy
1B USD
IS THE COST TO DEVELOP EACH ANTI-CANCER DRUG
We are Marie-Agnès Doucey and Riccardo Turrini, co-founders of Calico Biosystems.
We have been educated as scientists, like many of you. Over the years, we have witnessed the critical issue of the limited efficacy of anti-cancer drugs in patients with solid tumors, the huge attrition rate of drugs from the pre-clinical stage to approval for use in patients, and their high development costs.
We want to change the status quo and provide cancer patients with new effective drugs, more potent combinations of therapies, and a real chance to get cured. Together, we have founded Calico Biosystems.
Partner with us to join the revolution of Precision Oncology.
MEET OUR TEAM AND BOARDS
Our Team
Marie-Agnès Doucey, PhD & engineer CEO and co-founder
15+ yrs as head of RnD and drug development programs in Oncology in public and private sectors, VP in Oncology
Riccardo Turrini, PhD in Oncology/Immunology CSO and
co-founder
15+ yrs experience in deciphering the immune response in tumors, program and team leader
Olivier Lacoste, MBA CFO
30+ yrs international experience 20 yrs M&A and Business Dev. 10+ yrs in Pharma Pharma and CRO network
Our Scientific Board
Our Scientific Board
Our Advisory Board
Michael Pittet, Director
Translation Oncology, HUG Translational oncology expert
Michael Pittet, Director
Translation Oncology, HUG Translational oncology expert
Michail Ignatiadis, Director
Clinical Oncology, Jules Bordet Institute, Brussels; chair at the EORTC Clinical oncology expert
Michail Ignatiadis, Director
Clinical Oncology, Jules Bordet Institute, Brussels; chair at the EORTC Clinical oncology expert
Our Advisory Board
Jean Pierre Wery
Former CTO of Crown Bioscience/ JSR LifeSciences, CEO SideWinder Therapeutics Network and contact with VCs and customers
Jean Pierre Wery
Former CTO of Crown Bioscience/ JSR LifeSciences, CEO SideWinder Therapeutics Network and contact with VCs and customers
Ioannis Xenarios
Professor, Unil, Head of Systems Computational Bioinformatics, Health2030 Genome Center. Our bioinformatic expert & counselor
Ioannis Xenarios
Professor, Unil, Head of Systems Computational Bioinformatics, Health2030 Genome Center. Our bioinformatic expert & counselor
